In addition to the loss of nuclear MSH2 expression in malignant neoplasms, aberrant cytoplasmic immunoreactivity was observed in a mixed mucinous and medullary CRC, the normal colonic mucosa counterpart, and in a poorly differentiated gastric carcinoma from patients of family 5 (#12 and #13). Here, MSH2 is linked to colorectal carcinoma.